Clinical Trials Logo

Clinical Trial Summary

Post Market, Prospective, Randomized, Controlled, multi center data collection study to evaluate the use of Viz versus the standard of care in stroke workflow and clinical outcome parameters.


Clinical Trial Description

This study will be a multicenter, multi arm, prospective randomized study to evaluate the use of Viz. The study will enroll all subjects that present at all participating centers that meet the study inclusion/exclusion during the period of study evaluation. All subject imaging (CT) data will be pushed to Viz and evaluated by Viz. Randomization will occur at the time of image processing by Viz that indicates the subject is positive for LVO per the software criteria (anterior location). Subjects randomized to the standard of care arm of the study will not receive any information via an automated notification from Viz. Subjects that are randomized to the Viz arm of the study will have an automated message sent to the enrolling center contacts. Subjects will be followed for 90 days post treatment. Data evaluation may occur at regular intervals throughout the study and at the completion of the study period. ;


Study Design


Related Conditions & MeSH terms

  • Stroke Workflow and Clinical Outcome Parameters

NCT number NCT04142879
Study type Observational
Source Providence Little Company of Mary-Torrance
Contact Diana Gallegos, LVN
Phone 310-303-5515
Email diana.gallegos@providence.org
Status Not yet recruiting
Phase
Start date December 1, 2019
Completion date December 31, 2021